2 Batten Disease Clinical Trials Enrolling Patients to Test Gene Therapies
Screening for Monoclonal Gammopathy of Undetermined Significance: First Results from the iStopMM Study
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
New IMWG Criteria Reflect Change in Practice - Clinical Oncology News
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma | Future Oncology
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) | Leukemia
Treatment Strategies for Patients with Multiple Myeloma: from Clinical Trials to Real Life | Frontiers Research Topic
Prevention of progression in monoclonal gammopathy of undetermined significance. - Abstract - Europe PMC
MGUS Clinical Trials
Multiple Myeloma Support + Trials
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
PLOS Medicine: Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
MGUS Clinical Trials
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Meeting Library | Psychosocial effects of the relaxation response resiliency program (SMART-3RP) in patients with MGUS and smoldering multiple myeloma: A waitlist controlled randomized clinical trial.
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Treatment of Smoldering Myeloma Delays Disease Progression, Yet Questions Remain
Multiple Myeloma Clinical Trials
